Merck & Co. Inc. (MRCK34)
(Delisted)Bovespa
Closed
Jul 24, 2026
Day's Range
82.9152 wk Range
51.86Profile - MRCK34 - Merck & Co. Inc.
Profile
Mic Code
BVMF
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73K
Merck & Co. Inc. is a renowned pharmaceutical company that plays a crucial role in the healthcare industry by developing, manufacturing, and marketing innovative medicines and vaccines. Its primary function is to provide effective and safe treatment options for various medical conditions, thereby improving global health outcomes. The company's product portfolio spans across sectors such as oncology, cardiology, endocrinology, and vaccines, impacting multiple facets of human health and well-being. Known for its emphasis on research and development, Merck invests heavily in scientific innovation to address unmet medical needs. This dedication to advancing healthcare contributes significantly to its prominence in the pharmaceutical market, making it a key player in both the development of new therapies and the global distribution of essential medicines. Established in 1891 and headquartered in Kenilworth, New Jersey, Merck continues to expand its influence and maintain a significant presence in the life sciences sector.
Profile Details
Type
Depositary Receipt
Ceo
Mr. Robert M. Davis J.D.
Address
126 East Lincoln Avenue
City
Rahway
State
NJ
Zip
07065
Country
United States
Phone
908 740 4000
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
